首页> 外国专利> compound, pharmaceutical composition, methods for treating hepatitis c viral infection, basal cell carcinoma, actinic keratosis, genital papilloma viral infection, and hepatitis c viral infection, process for preparing a compound, and use of a compound

compound, pharmaceutical composition, methods for treating hepatitis c viral infection, basal cell carcinoma, actinic keratosis, genital papilloma viral infection, and hepatitis c viral infection, process for preparing a compound, and use of a compound

机译：化合物，药物组合物，治疗丙型肝炎病毒感染，基底细胞癌，光化性角化病，生殖器乳头瘤病毒感染和丙型肝炎病毒感染的方法，化合物的制备方法和化合物的用途

页面导航

摘要
著录项
相似文献

摘要

The present invention provides novel phospholipidated imidazoquinolines as tlr7 and tlr8 agonists, pharmaceutical compositions, therapeutic uses and processes for preparing them.

机译：本发明提供了作为tlr7和tlr8激动剂的新型磷脂酰咪唑并喹啉，药物组合物，治疗用途和制备它们的方法。

著录项

公开/公告号BR112018011929A2

专利类型
公开/公告日2018-11-27

原文格式PDF
申请/专利权人 GLAXOSMITHKLINE BIOLOGICALS S.A.;
展开▼

申请/专利号BR20181111929
发明设计人 DAVID A. JOHNSON;HELENE G. BAZIN-LEE;
展开▼

申请日2016-12-12
分类号A61K39/39;A61K31/4745;A61P17/12;A61P31/14;A61P31/20;A61P35;C07F9/6561;
国家 BR
入库时间 2022-08-21 12:03:34

相似文献

专利
外文文献
中文文献